Patent · US Active

Method and composition for treating tumors

US12186343B2 · kind B2 · utility

0Cited by

6References

20Claims

0Family size

Assignee

CRAGE MEDICAL CO., LIMITED · CN

Inventors

Zonghai LI · Shanghai, CN
Huamao WANG · Shanghai, CN
Min Zhou · Suzhou, CN

Key dates

Filing date	Mar 8, 2019
Grant date	Jan 7, 2025
Priority date	—
Expiry date	Oct 20, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/03
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided in the present invention are a composition of immune effector cells and a treatment kit including the composition of immune effector cells, wherein the composition of immune effector cells comprises an initial dose of immune effector cells and a subsequent dose of immune effector cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.